NCT06820060View on ClinicalTrials.gov

Clinical Performance of QIAstat-Dx® Meningitis/Encephalitis (ME) Panel Plus

Active, not recruitingOBSERVATIONAL

Enrollment

1,500

Participants

Timeline

Start Date

April 3, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2025

Conditions

MeningitisEncephalitis Infection

Trial Locations (1)

Unknown

QIAGEN, Manchester

All Listed Sponsors

lead

QIAGEN Gaithersburg, Inc

INDUSTRY